Pelthos Therapeutics PTHS Cash Flow Statement (2023-2026)

NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.24M-21.66M-48.49M
Depreciation and Depletion (Quarter) 0.75M
Share-based Compensation (Quarter) 4.67M
Deferred Taxes (Quarter) 7.85M
Asset Writedowns and Impairment (Quarter) 0.93M
Cash from Operations (Quarter) -20.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 1.08M2.04M
Amortization of Deferred Charges (Quarter) 0.14M
Depreciation & Amortization (CF) (Quarter) 0.75M
Change in Working Capital
Change in Account Payables (Quarter) 2.82M
Change in Accured Expenses (Quarter) 6.40M
Change in Receivables (Quarter) 5.62M
Change in Inventory (Quarter) -1.37M
Investing Activities
Cash from Investing Activities (Quarter) -0.20M
Capital Expenditures (Quarter) 0.20M
Financing Activities
Other financing activities (Quarter) 0.12M
Cash from Financing Activities (Quarter) 27.52M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 5.97M
Additional items
Change in Cash (Quarter) 6.54M
Free Cash Flow (Quarter) -20.99M
Net Cash Flow (Quarter) 6.54M